Trademark Overview
On Thursday, June 6, 2024, a trademark application was filed for WONDRLINK with the United States Patent and Trademark Office. The USPTO has given the WONDRLINK trademark a serial number of 98589288. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 25, 2025. This trademark is owned by Cancer Connector, LLC. The WONDRLINK trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Providing referrals and online referrals in the field of medical therapeutics, medical devices and medical therapies in development or under research for patients with lifethreatening or catastrophic illnesses; Providing referrals and online referrals in the field health care and medical treatment to connect patients, caregivers, health care providers, researchers, medical facilities, financial sponsors and support organizations with each other to enable access to care; Matching medical patients with caregivers, health care providers, researchers, medical facilities, financial sponsors and support organizations to enable access to care; Matching medical patients with available clinical trial and experimental treatment providers
Platform as a service (PAAS) featuring computer software platforms for providing referrals and online referrals in the field of medical therapeutics, medical devices and medical therapies in development or under research for patients with lifethreatening or catastrophic illnesses; Platform as a service (PAAS) featuring computer software platforms for providing referrals and online referrals in the field health care and medical treatment to connect patients, caregivers, health care providers, researchers, medical facilities, financial sponsors and support organizations with each other to enable access to care; Platform as a service (PAAS) featuring computer software platforms for matching medical patients with caregivers, health care providers, researchers, medical facilities, financial sponsors and support organizations to enable access to care; Platform as a service (PAAS) featuring computer software platforms for matching medical patients with available clinical trial and experimenta...
